Profile
Lumerate is launching a new software brand called BioBackers - the intelligence platform for life science fundraising. BioBackers delivers curated, near-real-time investor insights that helps therapeutics-focused life science companies discover and engage investors whose focus aligns with its venture's profile and fundraising goals, to help them efficiently secure capital and advance their therapeutic pipeline.
Event details
Date: December 1 - 5, 2025
Event contact
Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
13 in total
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for… -
Atorvia is pioneering first-in-class peptide therapeutics that treat organ failure, beginning with acute kidney… -
Aufero Medical is a Canadian medtech startup developing TruContact, a robotic tool that actively stabilizes… -
Cosm Medical is digitizing gynecological devices to personalize care for pelvic health issues that affect half of… -
Eurofins CDMO Alphora develops and manufactures small molecule and biologic drug substances and drug… -
Inertia is an award-winning Canadian med-device development services firm that helps medical and diagnostic… -
JN Nova's Two JN2019 Development Leads: A novel Long COVID therapeutic is scheduled to… -
Lumerate is launching a new software brand called BioBackers - the intelligence platform for life science… -
MEMOTEXT is a platform for co-creating digital patient engagement tools that personalize and scale evidence-based… -
Helping Biotech companies beat the odds - Omnium Global is an innovation company advancing life sciences through… -
Pulse Infoframe is a global healthcare company with a best-in-class real-world evidence platform that has… -
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide… -
VeriLuce Therapeutics is a biotech company focusing on the development of novel small molecules targeting in dual…